Open study to investigate if the eradication rate of H. pylori in adults is improved by L. reuteri DSM 17938, as an adjunct during 10-day eradication therapy and for 10 days thereafter. Forty-five (45) patients were included.
The rate of eradication was 93.3% (42/45). In 2/4 (50%) previously treated for H. pylori the infection was also eradicated.
Side effects were reported in 8 subjects: mild diarrhoea for a few days (n=5), and abdominal discomfort (n=3).
Conclusion: Proton pump inhibitor-tetracycline-metronidazole-L. reuteri therapy provided high eradication rates with few side effects, and excellent compliance.
Dore MP, Soro S, Rocchi C, Loria MF, Bibbò S, Pes GM. Inclusion of Lactobacillus reuteri in the treatment of Helicobacter pylori in Sardinian patients: a case report series. Medicine (Baltimore). 2016;95(15):e3411.